Press Releases

Date Title and Summary Additional Formats
Toggle Summary Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference
JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the Jefferies 2017 London Healthcare Conference on Thursday,
View HTML
Toggle Summary Quotient Limited Reports Second Quarter Fiscal 2018 Financial Results
MosaiQ project de-risked, Verification and Validation ("V&V") "head-to-head" studies confirm targeted concordance levels for all blood grouping assays European field trials planned to commence prior to year end Key financing completed, raising up to $89 million — critical element of funding plan
View HTML
Toggle Summary Quotient Reports Positive Concordance Data from MosaiQ Verification and Validation Studies for Blood Grouping and Announces Financing
Verification & Validation ("V&V") "head-to-head" studies confirm targeted concordance levels for all blood grouping assays Overall concordance for blood grouping — 99.8%, demonstrating the robustness of the MosaiQ platform European field trials planned to commence prior to year-end Announces the
View HTML
Toggle Summary Quotient Limited Announces $40 Million Private Placement and the Issue of Warrants to Raise up to an Additional $49 Million
JERSEY, Channel Islands, Oct. 25, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it has entered into agreements to issue to certain subscribers: (i) 7,864,683 ordinary shares at $4.64 per share (the "Ordinary Shares"); (ii)
View HTML
Toggle Summary Quotient Limited to Report Fiscal Second Quarter 2018 Financial Results and Host Conference Call
JERSEY, Channel Islands, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal second quarter ended September 30, 2017, will be released after market close on Monday, October 30, 2017.
View HTML
Toggle Summary Quotient Limited to Participate in the Cantor Fitzgerald 2017 Global Healthcare Conference
JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the Cantor Fitzgerald 2017 Global Healthcare Conference on
View HTML
Toggle Summary Quotient Limited Reports Results From Latest MosaiQ Performance Evaluation Studies Prior to Commencing Verification and Validation Studies
Performance evaluation studies confirm required concordance levels for all assays Verification and validation studies to commence shortly European field trials still expected to be completed in CY17 JERSEY, Channel Islands, Sept. 12, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a
View HTML
Toggle Summary Quotient Limited to Participate in the Morgan Stanley 15th Annual Global Healthcare Conference
JERSEY, Channel Islands, Aug. 30, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the Morgan Stanley 15 th Annual Global Healthcare Conference on
View HTML
Toggle Summary Quotient Limited Reports Results From Ongoing MosaiQ Performance Evaluation Studies and First Quarter Fiscal 2018 Financial Results
Latest performance evaluation studies confirm substantial concordance with predicate technologies for blood grouping and initial disease screening applications European field trials expected to be completed in CY17 Record reagent revenues recorded during the quarter, exceeding guidance Six new
View HTML
Toggle Summary Quotient Limited to Report Continued Progress on the Commercial Scale-Up of MosaiQ™ and Fiscal First Quarter 2018 Financial Results and Host Conference Call
JERSEY, Channel Islands, July 21, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that an update on the results of internal verification and validation studies for the MosaiQ™ system, as well as financial results for its fiscal
View HTML